-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
The benefits of including expansion cohorts in Phase I oncology clinical trial design
Aaron R Hansen, Albiruni RA Razak
Editorial: Clinical Investigation
-
The benefits of including expansion cohorts in Phase I oncology clinical trial design
Aaron R Hansen, Albiruni RA Razak
Editorial: Clinical Investigation
-
The benefits of including expansion cohorts in Phase I oncology clinical trial design
Aaron R Hansen, Albiruni RA Razak
Editorial: Clinical Investigation
-
The benefits of including expansion cohorts in Phase I oncology clinical trial design
Aaron R Hansen, Albiruni RA Razak
Editorial: Clinical Investigation
-
The benefits of including expansion cohorts in Phase I oncology clinical trial design
Aaron R Hansen, Albiruni RA Razak
Editorial: Clinical Investigation
-
The benefits of including expansion cohorts in Phase I oncology clinical trial design
Aaron R Hansen, Albiruni RA Razak
Editorial: Clinical Investigation
-
The benefits of including expansion cohorts in Phase I oncology clinical trial design
Aaron R Hansen, Albiruni RA Razak
Editorial: Clinical Investigation
-
The benefits of including expansion cohorts in Phase I oncology clinical trial design
Aaron R Hansen, Albiruni RA Razak
Editorial: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation